Dr. Piyush N. Joshi, M.D. First Melbourne Area Urologist to Treat Patients with the UroLift® System in Office

Share Article

Innovative Treatment for Enlarged Prostate Offers Rapid Symptom Relief and Recovery

News Image
The UroLift System provides fast and meaningful relief from BPH symptoms, improving overall quality of life for our patients

Dr. Piyush N. Joshi, a volunteer faculty at UCF as Professor of Urology, today announced that his office, OM Urology, is the first practice in Melbourne to treat benign prostatic hyperplasia (BPH) patients with the UroLift® System in the convenience of an office setting. The UroLift System is the first permanent implant to treat symptoms related to benign prostatic hyperplasia (BPH) in men 50 years of age or older. The UroLift System was cleared by the U.S. Food and Drug Administration in 2013, and is designed to relieve symptoms caused by an enlarged prostate while preserving sexual function.

“I am committed to providing patients with the highest quality, most effective options to address their urology needs,” said Dr. Joshi. “The UroLift System has an excellent safety profile and provides men suffering from an enlarged prostate a beneficial first-line treatment alternative to drug therapy or more invasive surgery.” Dr. Joshi is currently the only practice in the Melbourne area to offer this treatment to patients in his office under local anesthesia. The procedure typically takes one hour or less. “The UroLift System provides fast and meaningful relief from BPH symptoms, improving overall quality of life for our patients,” he added.

The UroLift System permanent implants, delivered during a minimally-invasive procedure, act like window curtain tie-backs to hold the lobes of an enlarged prostate open. Patients recover from the procedure quickly, and return to their normal routines with minimal downtime.
 
Data from clinical trials showed that patients receiving UroLift implants reported rapid symptomatic improvement, improved urinary flow rates, and sustained sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure.

The UroLift System was approved for Medicare payments in Florida in October, 2016. OM Urology is located at 3160, W. Eau Gallie Boulevard. To schedule a consultation with Dr. Joshi, please call (321) 241-6574.

About UroLift

The UroLift System provides an alternative to tissue removing surgery for the treatment of an enlarged prostate. Performed through the urethra, a urologist uses the UroLift System to push aside the obstructive prostate lobes and positions small, tailored permanent UroLift implants to hold the prostate lobes in the retracted position. This opens the urethra like window curtain tie-backs to hold the lobes of an enlarged prostate open while leaving the prostate intact. Patients recover from the procedure quickly, and return to their normal routines with minimal downtime.

Adverse reactions associated with UroLift System treatment were comparable to other minimally invasive surgical therapies as well as standard cystoscopy. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure.

Data from clinical trials showed that patients receiving UroLift implants reported rapid symptomatic improvement, improved urinary flow rates, and sustained sexual function. Patients also experienced a significant improvement in quality of life.

About BPH Treatments

More than 500 million aging men worldwide have an enlarged prostate. Medication is often the first line therapy but relief can be inadequate and temporary. Side effects of treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts or ablates prostate tissue to open the blocked urethra. While current surgical options, such as the 'gold standard' surgery, Transurethral Resection of the Prostate (TURP), can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as retrograde ejaculation (dry orgasm).

                                                                                         ###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sierra Smith
Health+Commerce
+1 4085404296
Email >